Spotlight On... China halts track-and-trace project because of complaints against Alibaba; Baxter recalls potentially insect tainted saline; Indian drugmakers focus on quality; and more...

China's FDA has put a moratorium on an electronic drug tracking system after a lawsuit was filed alleging that Hong Kong-listed Alibaba Health Information Technology, or Ali Health, which is designing it, was gaining an unfair trade advantage over other drug sellers. The Alibaba Group last year moved to get a controlling stake in Ali Health in hopes that online drug sales will be approved. At the same time, it has been working on offering online over-the-counter sales. More from FiercePharmaAsia

> Some of India's largest drugmakers have formed an alliance to set manufacturing standards and oversee progress at plants in an effort to better meet the expectations of the FDA, which has repeatedly cited the Indian drugmaker for GMP issues. Story

> Baxter recalled saline solution used for irrigation after an insect was again reported in a container. Report

> To fight counterfeit drugs, the European Medicines Agency (EMA) and the European Commission have ordered manufacturers to include a unique identifier on a 2-D barcode, as well as an antitampering device. Report

> Oxford BioMedica intends to sell shares to raise £8.1 million to be used in part to expand development of lentiviral vector manufacturing-related technology. Release

Suggested Articles

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.